Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Chronic allograft injury by subclinical borderline change: evidence from serial protocol biopsies in kidney transplantation

´ëÇÑ¿Ü°úÇÐȸÁö 2012³â 83±Ç 6È£ p.343 ~ 351
¹Î»óÀÏ, ¹Ú¿µ¼®, ¾È»óÇö, ¹ÚÅÂÁø, ¹Ú´ëµµ, ±è¼­¹Î, ¹®°æö, ¹Î½Â±â, ±è¿¬¼ö, ¾È±Ô¸®, ±è»óÁØ, ÇÏÁ¾¿ø,
¼Ò¼Ó »ó¼¼Á¤º¸
¹Î»óÀÏ ( Min Sang-Il ) 
Seoul National University College of Medicine Department of Surgery

¹Ú¿µ¼® ( Park Young-Suk ) 
Seoul National University College of Medicine Department of Surgery
¾È»óÇö ( Ahn Sang-Hyun ) 
Seoul National University College of Medicine Department of Surgery
¹ÚÅÂÁø ( Park Tae-Jin ) 
Seoul National University College of Medicine Department of Surgery
¹Ú´ëµµ ( Park Dae-Do ) 
Seoul National University College of Medicine Department of Surgery
±è¼­¹Î ( Kim Suh-Min ) 
Seoul National University College of Medicine Department of Surgery
¹®°æö ( Moon Kyung-Chul ) 
Seoul National University College of Medicine Department of Pathology
¹Î½Â±â ( Min Seung-Kee ) 
Seoul National University College of Medicine Department of Surgery
±è¿¬¼ö ( Kim Yon-Su ) 
Seoul National University College of Medicine Department of Internal Medicine
¾È±Ô¸® ( Ahn Curie ) 
Seoul National University College of Medicine Department of Internal Medicine
±è»óÁØ ( Kim Sang-Joon ) 
Seoul National University College of Medicine Department of Surgery
ÇÏÁ¾¿ø ( Ha Jong-Won ) 
Seoul National University College of Medicine Department of Surgery

Abstract


Purpose: This study investigated the impact of subclinical borderline changes on the development of chronic allograft injury in patients using a modern immunosuppression protocol. Methods: Seventy patients with stable renal allograft function and who underwent protocol biopsies at implantation, 10 days and 1 year after transplantation were included and classified based on biopsy findings at day 10. The no rejection (NR) group included 33 patients with no acute rejection. The treatment (Tx) group included 21 patients with borderline changes following steroid pulse therapy, and the nontreatment (NTx) group included 16 patients with borderline changes nontreated. Results: The Banff Chronicity Score (BChS) and modified BChS (MBChS) were not different among the three groups at implantation (P = 0.48) or on day 10 (P = 0.96). Surprisingly, the NTx group had more prominent chronic scores at the 1-year biopsy, including BChS (3.07 ¡¾ 1.33, P = 0.005) and MBChS (3.14 ¡¾ 1.41, P = 0.008) than those in the Tx and NR group, and deterioration of BChS was more noticeable in the NTx group (P = 0.037), although renal function was stable (P = 0.66). No difference in chronic injury scores was observed between the Tx and NR groups at the 1-year biopsy. Conclusion: Subclinical borderline changes can be a risk factor for chronic allograft injury and should be considered for antirejection therapy.

Å°¿öµå

Borderline change; Chronic allograft injury; Kidney transplantation; Protocol kidney biopsy; Steroid pulse therapy

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS